机构:[1]Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai, Peoples R China[2]Fudan Univ, Canc Hosp, Dept Med Oncol, Shanghai, Peoples R China[3]Zhejiang Canc Hosp, Dept Breast Med Oncol, Hangzhou, Peoples R China浙江省肿瘤医院[4]Soochow Univ, Affiliated Hosp 1, Dept Gen Surg, Suzhou, Peoples R China[5]Soochow Univ, Affiliated Hosp 1, Dept Oncol, Suzhou, Peoples R China[6]Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Peoples R China[7]Hebei Univ,Affiliated Hosp,Dept Med Oncol,Baoding,Peoples R China医疗肿瘤内科河北大学附属医院重点学科肿瘤内科[8]Burning Rock Biotech, Guangzhou, Peoples R China
Tao Zhonghua,Hu Xichun,Cao Wen-Ming,et al.Profiling receptor tyrosine kinase fusions in Chinese breast cancers[J].JOURNAL OF CLINICAL ONCOLOGY.2021,39(15):doi:10.1200/JCO.2021.39.15_suppl.e15092.
APA:
Tao, Zhonghua,Hu, Xichun,Cao, Wen-Ming,Liu, Jianxia,Li, Ting...&Li, Min.(2021).Profiling receptor tyrosine kinase fusions in Chinese breast cancers.JOURNAL OF CLINICAL ONCOLOGY,39,(15)
MLA:
Tao, Zhonghua,et al."Profiling receptor tyrosine kinase fusions in Chinese breast cancers".JOURNAL OF CLINICAL ONCOLOGY 39..15(2021)